Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.280
-0.070 (-5.19%)
At close: Aug 24, 2026, 4:00 PM EDT
1.310
+0.030 (2.34%)
Pre-market: Aug 25, 2026, 4:53 AM EDT

PACB Statistics

Total Valuation

PACB has a market cap or net worth of $397.86 million. The enterprise value is $870.12 million.

Market Cap397.86M
Enterprise Value 870.12M

Important Dates

The last earnings date was Wednesday, August 5, 2026, after market close.

Earnings Date Aug 5, 2026
Ex-Dividend Date n/a

Share Statistics

PACB has 310.83 million shares outstanding. The number of shares has increased by 5.75% in one year.

Current Share Class 310.83M
Shares Outstanding 310.83M
Shares Change (YoY) +5.75%
Shares Change (QoQ) +1.58%
Owned by Insiders (%) 1.07%
Owned by Institutions (%) 59.29%
Float 304.01M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.50
Forward PS 2.35
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 5.46
EV / EBITDA 4.37
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.92

Current Ratio 4.92
Quick Ratio 3.89
Debt / Equity n/a
Debt / EBITDA 3.39
Debt / FCF n/a
Interest Coverage -24.22

Financial Efficiency

Return on equity (ROE) is -929.32% and return on invested capital (ROIC) is -15.42%.

Return on Equity (ROE) -929.32%
Return on Assets (ROA) -14.07%
Return on Invested Capital (ROIC) -15.42%
Return on Capital Employed (ROCE) -25.99%
Weighted Average Cost of Capital (WACC) 6.63%
Revenue Per Employee $328,394
Profits Per Employee -$270,901
Employee Count485
Asset Turnover 0.20
Inventory Turnover 1.96

Taxes

In the past 12 months, PACB has paid $827,000 in taxes.

Income Tax 827,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -7.25% in the last 52 weeks. The beta is 2.32, so PACB's price volatility has been higher than the market average.

Beta (5Y) 2.32
52-Week Price Change -7.25%
50-Day Moving Average 1.40
200-Day Moving Average 1.65
Relative Strength Index (RSI) 48.94
Average Volume (20 Days) 7,062,203

Short Selling Information

The latest short interest is 49.00 million, so 15.77% of the outstanding shares have been sold short.

Short Interest 49.00M
Short Previous Month 46.24M
Short % of Shares Out 15.77%
Short % of Float 16.12%
Short Ratio (days to cover) 8.42

Income Statement

In the last 12 months, PACB had revenue of $159.27 million and -$131.39 million in losses. Loss per share was -$0.43.

Revenue159.27M
Gross Profit 46.86M
Operating Income -177.54M
Pretax Income -130.56M
Net Income -131.39M
EBITDA 199.18M
EBIT -177.54M
Loss Per Share -$0.43
Full Income Statement

Balance Sheet

The company has $236.87 million in cash and $709.13 million in debt, with a net cash position of -$472.25 million or -$1.52 per share.

Cash & Cash Equivalents 236.87M
Total Debt 709.13M
Net Cash -472.25M
Net Cash Per Share -$1.52
Equity (Book Value) -33.21M
Book Value Per Share -0.11
Working Capital 269.83M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$118.05 million and capital expenditures -$5.37 million, giving a free cash flow of -$123.42 million.

Operating Cash Flow -118.05M
Capital Expenditures -5.37M
Depreciation & Amortization 376.71M
Net Borrowing n/a
Free Cash Flow -123.42M
FCF Per Share -$0.40
Full Cash Flow Statement

Margins

Gross margin is 29.42%, with operating and profit margins of -111.47% and -82.49%.

Gross Margin 29.42%
Operating Margin -111.47%
Pretax Margin -81.97%
Profit Margin -82.49%
EBITDA Margin 125.05%
EBIT Margin -111.47%
FCF Margin n/a

Dividends & Yields

PACB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -5.75%
Shareholder Yield n/a
Earnings Yield -33.02%
FCF Yield -31.02%

Analyst Forecast

The average price target for PACB is $2.29, which is 78.91% higher than the current price. The consensus rating is "Buy".

Price Target $2.29
Price Target Difference 78.91%
Analyst Consensus Buy
Analyst Count 7
Revenue Growth Forecast (3Y) 10.13%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

PACB has an Altman Z-Score of -4.88 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -4.88
Piotroski F-Score 3